Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
QUALE ITER DIAGNOSTICO NEI LUNGO VIVENTI AL CANCRO CON DOLORE TORACICO? DESCRIZIONE DI UN CASO CLINICO
Anno:
2023
Introduzione Cancro e Malattie CV condividono spesso fattori di rischio e meccanismi fisiopatologici comuni, la relazione può essere amplificato dal trattamento oncologico. Nel caso degli inibitori dell’aromatasi (IA), utilizzati per lungo tempo nel cancro mammario (CM) che esprime il recettore per gli estrogeni vi è una associazione significativa con…
Leggi di più
Radiotherapy and the heart: in search of Arianna’s thread
Anno:
2023
Background: Radiation therapy (RT) is widely diffused in the treatment of cancer; but it could lead to various negative consequences on the cardiovascular system, even several years after treatment end. They include also valvular heart diseases, arrythmias, coronary artery diseases, heart failure, pericardial diseases, systemic and pulmonary artery diseases….
Leggi di più
TEAMWORK IS SUCCESSFUL (1): FAVOUREABLE RE-CHALLENGE OF DOUBLE ANTI-HER2 TREATMENT IN SEVERE MYOCARDIAL DYSFUNCTION IN PATIENT WITH ADVANCED BREAST CANCER AND OCCULT TYPE II DIABETES
Anno:
2023
INTRODUCTION Cardiovascular diseases (CVD) and Cancer (C), the most important causes of mortality worldwide. share many risk factors and common pathophysiological processes such as chronic inflammation and unfavorable cardio-metabolic profile. Progress in oncological treatments improved the survival of oncological patients (Pt) but have increased the likelihood of short- and…
Leggi di più
TEAMWORK IS SUCCESSFUL (2): PATIENT WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AND MULTIPLE HEART MASSES
Anno:
2023
Introduction Patients (Pts) with lymphoma are at high risk of cardiovascular events for the cardiotoxic effects of therapies and direct involvement of the heart. Autopsy series, indeed, indicate that cardiac localization may be observed in 10 – 25% of DLBCL Pts. The presence of cardiac mass, in DLBCL poses…
Leggi di più
TEAMWORK IS SUCCESSFUL (3): IMMUNOTHERAPY WITH IMMUNE CHECKPOINT INHIBITORS (ICIs) FAVOURABLE RESPONSE AND CARDIOVASCULAR COMPLICATION. A CASE REPORT
Anno:
2023
Immunotherapy in recent years has revolutionized the oncology practice. ICIs targeting T lymphocyte antigen-4 (CTLA-4) and programmed death-1/ligand-1 (PD-1/PD-L1) transformed treatment landscape of many different cancers. The answers occur in a substantial fraction of patients and are often durable. ICI's combined block (CB) (CTLA-4 + PD-1/PD-L1) seems to improve…
Leggi di più
Mediastinal round cell sarcoma with pulmonary artery stenosis: Clinical usefulness of cardiac MRI in Cardio-Oncology
Anno:
2023
Case description: a previously healthy 26-year-old man presented with dyspnea on exertion and dry cough. CT scan revealed a large mediastinal mass with displacement of great vessels and trachea and pericardial effusion. Cardiac MRI showed the huge mediastinal mass, literally leaning on the heart with signs of compression of…
Leggi di più
INTRA-CARDIAC AND ALL LAYERS CARDIAC INVOLVEMENT BY SQUAMOUS NON-SMALL CELL LUNG CANCER.
Anno:
2023
  A 73 year-old man was referred by his general practitioner to our ambulatory for worsening dyspnea. He also reported substantial weight loss (almost 20 kg during the last three months), new onset dysphonia and dry cough. The patient’s medical history also included a former tobacco addiction, arterial hypertension…
Leggi di più
Next Generation myocarditis
Anno:
2023
A 75-year-old overweight man, affected by hypertension, diabetes mellitus and atrial fibrillation since 2020. After 3 unsuccessful attempts of electrical cardioversion it was opted for a strategy of rate control with beta blocker and anticoagulant therapy with Rivaroxaban 20 mg. Following episodes of rectal bleeding; adenocarcinoma of the colon…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram